Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Feighner

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The Journal of Clinical Psychiatry|August 1, 1991
Double-blind comparison of bupropion and fluoxetine in depressed outpatientsJ P Feighner, E A Gardner, J A Johnston, et al.
International Clinical Psychopharmacology|November 20, 2001
Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depressionJ P Feighner, R H Ehrensing, A J Kastin, et al.
Journal of Affective Disorders|January 11, 2000
The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patientsJ P Kelly, G Nicolau, A Redmond, et al.
Journal of Affective Disorders|December 2, 2000
A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depressionJ P Feighner, R H Ehrensing, A J Kastin, et al.
The Journal of Clinical Psychiatry|September 1, 1995
Bupropion: a review of its mechanism of antidepressant activityJ A Ascher, J O Cole, J N Colin, et al.
The Journal of Clinical Psychiatry|May 1, 1990
A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatientsC G Lineberry, J A Johnston, R N Raymond, et al.
The Journal of Clinical Psychiatry|February 11, 1992
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depressionD L Dunner, J B Cohn, T Walshe, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Journal of Clinical Psychiatry|August 1, 1991
Double-blind comparison of bupropion and fluoxetine in depressed outpatientsJ P Feighner, E A Gardner, J A Johnston, et al.
International Clinical Psychopharmacology|November 20, 2001
Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depressionJ P Feighner, R H Ehrensing, A J Kastin, et al.
Journal of Affective Disorders|January 11, 2000
The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patientsJ P Kelly, G Nicolau, A Redmond, et al.
Journal of Affective Disorders|December 2, 2000
A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depressionJ P Feighner, R H Ehrensing, A J Kastin, et al.
The Journal of Clinical Psychiatry|September 1, 1995
Bupropion: a review of its mechanism of antidepressant activityJ A Ascher, J O Cole, J N Colin, et al.
The Journal of Clinical Psychiatry|May 1, 1990
A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatientsC G Lineberry, J A Johnston, R N Raymond, et al.
The Journal of Clinical Psychiatry|February 11, 1992
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depressionD L Dunner, J B Cohn, T Walshe, et al.
Pageof 8